To find out the relevance of serum magnesium levels on the outcome of patients admitted in ICU.
Phase 2
Completed
- Conditions
- Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Registration Number
- CTRI/2019/02/017826
- Lead Sponsor
- The head of the department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 280
Inclusion Criteria
Critically ill patients admitted to ICU
AGE LIMIT: 18 years and above
Exclusion Criteria
Patients with documented hypomagnesemia / hypermagnesemia before admission to ICU
-Patients with previous magnesium supplementation
-Mortality within 24 hours of admission to ICU
-Critically ill patients in ICU in whom day 1 of serum magnesium testing is missed .
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method